Changeflow GovPing Healthcare & Life Sciences Autoimmune Hyperthyroidism in Prepubertal Child...
Routine Notice Added Final

Autoimmune Hyperthyroidism in Prepubertal Children, NCT07544290

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

A multicenter retrospective observational study (NCT07544290) registered on ClinicalTrials.gov will assess clinical, biochemical, and auxological characteristics at diagnosis and during follow-up in Caucasian pediatric patients diagnosed with autoimmune hyperthyroidism before puberty. The study will compare prepubertal patients with a control group of post-pubertal patients with Graves' disease to identify age-dependent clinical patterns, therapeutic response, and growth-related outcomes. The study aims to support more tailored management strategies in pediatric populations.

“These prepubertal patients will be compared with a control group of post-pubertal patients with Graves' disease.”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.

What changed

The study record for NCT07544290 documents a new multicenter retrospective observational study registered with ClinicalTrials.gov, examining autoimmune hyperthyroidism in prepubertal children. The study will collect clinical, biochemical, and auxological data at diagnosis and follow-up, comparing prepubertal patients with post-pubertal controls to identify age-dependent patterns and prognostic indicators. Healthcare institutions and clinical investigators participating in or referring patients to this study should ensure alignment with their IRB-approved protocols and confirm accuracy of enrollment data in the ClinicalTrials.gov record.

Scheduled event

Date
2026-04-22

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Autoimmune Hyperthyroidism in Prepubertal Children

Observational NCT07544290 Kind: OBSERVATIONAL Apr 22, 2026

Abstract

The investigators propose a multicenter retrospective study to assess clinical, biochemical, and auxological characteristics at diagnosis and during follow-up in a cohort of Caucasian pediatric patients diagnosed with autoimmune hyperthyroidism before puberty. These prepubertal patients will be compared with a control group of post-pubertal patients with Graves' disease.

This study aims to enhance the understanding of autoimmune hyperthyroidism in prepubertal patients by providing a detailed evaluation of disease onset, therapeutic response, and growth-related outcomes. The inclusion of a carefully matched post-pubertal control group will allow for robust comparative analysis and identification of age-dependent clinical patterns and prognostic indicators, ultimately supporting more tailored and effective management strategies in pediatric populations at this particular age.

Conditions: Autoimmune Hyperthyroidism, Children

Interventions: restrospective observational study

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 22nd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers Clinical investigators Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Clinical research Pediatric endocrinology study Observational study registration
Geographic scope
United States US

Taxonomy

Primary area
Public Health
Operational domain
Clinical Operations
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!